INPP4B and breast carcinoma: Our discovery that INPP4B promotes oncogenic signaling in PIK3CA-mutant ER+ breast cancer, despite suppressing AKT signaling, suggests Wnt/β-catenin rather than AKT activation is responsible for the hyper-proliferation.